ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

ELIZABETH KRELL FAMILY NURSE PRACTIT

At A Glance: This Prescriber in 2012

Nurse Practitioner, Primary Care

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,673Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 30

$534K Total Retail Price of All Prescriptions

Rank: 2 out of 30

449 Patients Receiving at Least One Drug in Part D
27%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

35% of this provider’s 449 patients filled at least one prescription for a schedule two drug, compared to an average of 12%.

Schedule Three
Controlled Substances

53% of this provider’s 449 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

5% of this provider’s 3,625 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 1,289 433 S3 1 1
LISINOPRIL 416 142 2 3
OMEPRAZOLE 391 135 3 4
ENDOCET 322 81 S2 4 27
GABAPENTIN 283 98 5 8
ATENOLOL 276 111 6 17
SIMVASTATIN 270 100 7 2
ZOLPIDEM TARTRATE 254 72 8 19
FUROSEMIDE 251 75 9 6
METOPROLOL TARTRATE 230 75 10 11
PROMETHAZINE HCL 229 48 R 11 25
OXYCODONE HCL 228 50 S2 12 20
LEVOTHYROXINE SODIUM 224 77 13 5
TIZANIDINE HCL 208 39 14 37
HYDROCHLOROTHIAZIDE 197 110 15 9
METFORMIN HCL 183 57 16 7
AMLODIPINE BESYLATE 173 103 17 10
PROAIR HFA 170 60 18 21
CARISOPRODOL 160 33 R 19 23
RANITIDINE HCL 155 33 20 13
CYCLOBENZAPRINE HCL 155 35 R 20 33
NEXIUM 149 60 22 12
SERTRALINE HCL 108 58 23 39
CYMBALTA 108 40 23 53
OXYCODONE HCL-ACETAMINOPHEN 105 25 S2 25 49
MELOXICAM 103 28 26 18
GEMFIBROZIL 100 17 27 78
AZITHROMYCIN 97 32 28 34
GLYBURIDE 92 34 R 29 59
ATORVASTATIN CALCIUM 88 32 30 31
LOVASTATIN 86 18 31 42
VENTOLIN HFA 84 18 32 82
POTASSIUM CHLORIDE 84 29 32 15
SPIRIVA 82 19 34 35
WARFARIN SODIUM 81 27 35 22
FLUOXETINE HCL 75 11 36 68
PANTOPRAZOLE SODIUM 73 30 37 75
CITALOPRAM HBR 72 49 38 14
ISOSORBIDE MONONITRATE ER 71 21 39 79
SINGULAIR 70 0 40 69
TRAZODONE HCL 67 22 41 40
TRICOR 65 17 42 85
LYRICA 64 0 43 60
FLUCONAZOLE 61 14 44 74
DEXILANT 61 18 44 63
ESTRADIOL 59 20 R 46 119
ALLOPURINOL 57 27 47 58
IBUPROFEN 55 0 48 94
FAMOTIDINE 52 0 49 44
AMOXICILLIN 52 0 49 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.